Strain promoted click labeling of oligonucleotides on solid-phase support
Methods · 2025
DOI: 10.1016/j.ymeth.2025.09.001 ↗Kurz gefasst
Fachartikel in der Zeitschrift Methods, 2025. Verfasst von Michaela Beranova und 6 weiteren Autor:innen. Beteiligte Einrichtung: Charles University, Faculty of Pharmacy in Hradec Kralove, Ak. Heyrovskeho 1203, Hradec Kralove 500 03, Czech Republic; Generi Biotech, U Fotochemy 1…. Hauptthemen laut MEDLINE: Solid-Phase Synthesis Techniques, Oligonucleotides. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Research Council, European Commission, Charles University.
Abstract (Originalsprache)
Chemically modified oligonucleotides (ONs) are essential tools in molecular biology, diagnostics, and therapeutics. Strain-promoted azide-alkyne cycloaddition (SPAAC) offers an efficient and bioorthogonal method for ON functionalization. While SPAAC reactions on solid-phase support provide distinct advantages, particularly for the incorporation of lipophilic labels, factors influencing their efficiency remain poorly characterized. The interplay between the physicochemical properties of the modifying molecule, the nature of the solid support, and the labeling site within the ON chain has not been systematically evaluated. In this study, we systematically investigate how modifying molecule properties (size, polarity) and concentration, solid support type, labeling site within the ON chain, and reaction time influence efficiency of labeling. Our findings demonstrate that while polar modifying molecules react efficiently across all solid supports, lipophilic molecules can exhibit reduced reactivity on glass-based supports, particularly in positions close to the 3́-end of the oligonucleotide attached to the support. We further show that conjugation at the 5'-terminus consistently yields the highest efficiencies, with a gradual decline observed as the modification site approaches the 3'-end. A 1 mM concentration of labeling reagent was sufficient to achieve high yields on polystyrene support for all labels and on CPG 500 for the polar labels. The size of the modifying molecule had a lesser effect compared to other factors. The method also benefits from recovery and reusability of the unreacted label. These results enable the rational design of efficient ON labeling protocols on solid-phase support while minimizing reagent consumption, contributing to both cost-effectiveness and environmental sustainability.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Charles University, Faculty of Pharmacy in Hradec Kralove, Ak. Heyrovskeho 1203, Hradec Kralove 500 03, Czech Republic; Generi Biotech, U Fotochemy 1763, Hradec Kralove 500 02, Czech Republic.
- Charles University, Faculty of Pharmacy in Hradec Kralove, Ak. Heyrovskeho 1203, Hradec Kralove 500 03, Czech Republic.
- Charles University, Faculty of Pharmacy in Hradec Kralove, Ak. Heyrovskeho 1203, Hradec Kralove 500 03, Czech Republic. Electronic address: miletin@faf.cuni.cz.
Förderung
- European Research Council
- European Commission
- Charles University
- Ministry of Education Youth and Sports of the Czech Republic
Zitieren
APA
Beranova, M., Grossova, P., Demuth, J., Kostelansky, F., Novakova, V., Zimcik, P., & Miletin, M. (2025). Strain promoted click labeling of oligonucleotides on solid-phase support. Methods. https://doi.org/10.1016/j.ymeth.2025.09.001
Vancouver
Beranova M, Grossova P, Demuth J, Kostelansky F, Novakova V, Zimcik P, et al. Strain promoted click labeling of oligonucleotides on solid-phase support. Methods. 2025. doi:10.1016/j.ymeth.2025.09.001
BibTeX
@article{Beranova2025,
author = {Beranova, Michaela and Grossova, Petra and Demuth, Jiri and Kostelansky, Filip and Novakova, Veronika and Zimcik, Petr and Miletin, Miroslav},
title = {Strain promoted click labeling of oligonucleotides on solid-phase support},
journal = {Methods},
year = {2025},
doi = {10.1016/j.ymeth.2025.09.001}
}
EUVIMED